2-[(2-氯苯基)甲基氨基]-1,3-噻唑-4-酮 | 102589-13-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-[(2-氯苯基)甲基氨基]-1,3-噻唑-4-酮
• 英文名称: 2-(2-chloro-benzylamino)-thiazol-4-one
• 英文别名: 2-(2-Chlor-benzylamino)-thiazol-4-on；2-{[(2-Chlorophenyl)methyl]amino}-1,3-thiazol-4(5H)-one；2-[(2-chlorophenyl)methylimino]-1,3-thiazolidin-4-one
• CAS: 102589-13-9
• 化学式: C₁₀H₉ClN₂OS
• 分子量: 240.713
• InChiKey: URINVVRPDDSCTN-UHFFFAOYSA-N

物化性质

• 熔点：
  212 °C
• 沸点：
  382.0±44.0 °C(Predicted)
• 密度：
  1.44±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  66.8
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-吲哚甲醛 、 2-[(2-氯苯基)甲基氨基]-1,3-噻唑-4-酮 在 哌啶 作用下， 以 乙醇 为溶剂， 反应 8.0h， 以70%的产率得到5-((1H-indol-3-yl)methylene)-2-((2-chlorobenzyl)imino)thiazolidin-4-one
  参考文献：
  名称：

  Discovery of certain benzyl/phenethyl thiazolidinone-indole hybrids as potential anti-proliferative agents: Synthesis, molecular modeling and tubulin polymerization inhibition study

  摘要：

  A series of certain benzyl/phenethyl thiazolidinone-indole hybrids were synthesized for the study of anti-proliferative activity against A549, NCI-H460 (lung cancer), MDA-MB-231 (breast cancer), HCT-29 and HCT-15 (colon cancer) cell lines by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). We found that compound G37 displayed highest cytotoxicity with IC50 value of 0.92 +/- 0.12 mu M towards HCT-15 cancer cell line among all the synthesized compounds. Moreover, compound G37 was also tested on normal human lung epithelial cells (L132) and was found to be safe in contrast to HCT-15 cells. The lead compound G37 showed significant G2/M phase arrest in HCT-15 cells. Additionally, compound G37 significantly inhibited tubulin polymerization with IC50, value of 2.92 +/- 0.23 mu M. Mechanistic studies such as acridine orange/ethidium bromide (AO/EB) dual staining, DAPI nuclear staining, annexinV/propidium iodide dual staining, donogenic growth inhibition assays inferred that compound G37 induced apoptotic cell death in HCT-15 cells. Moreover, loss of mitochondrial membrane potential with elevated intracellular ROS levels was observed by compound G37. These compounds bind at the active pocket of the alpha/beta-tubulin with higher number of stable hydrogen bonds, hydrophobic and arene-cation interactions confirmed by molecular modeling studies.

  DOI：

  10.1016/j.bioorg.2019.103188
• 作为产物：
  描述：

  邻氯苯甲胺 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 10.0h， 生成 2-[(2-氯苯基)甲基氨基]-1,3-噻唑-4-酮
  参考文献：
  名称：

  Discovery of certain benzyl/phenethyl thiazolidinone-indole hybrids as potential anti-proliferative agents: Synthesis, molecular modeling and tubulin polymerization inhibition study

  摘要：

  A series of certain benzyl/phenethyl thiazolidinone-indole hybrids were synthesized for the study of anti-proliferative activity against A549, NCI-H460 (lung cancer), MDA-MB-231 (breast cancer), HCT-29 and HCT-15 (colon cancer) cell lines by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). We found that compound G37 displayed highest cytotoxicity with IC50 value of 0.92 +/- 0.12 mu M towards HCT-15 cancer cell line among all the synthesized compounds. Moreover, compound G37 was also tested on normal human lung epithelial cells (L132) and was found to be safe in contrast to HCT-15 cells. The lead compound G37 showed significant G2/M phase arrest in HCT-15 cells. Additionally, compound G37 significantly inhibited tubulin polymerization with IC50, value of 2.92 +/- 0.23 mu M. Mechanistic studies such as acridine orange/ethidium bromide (AO/EB) dual staining, DAPI nuclear staining, annexinV/propidium iodide dual staining, donogenic growth inhibition assays inferred that compound G37 induced apoptotic cell death in HCT-15 cells. Moreover, loss of mitochondrial membrane potential with elevated intracellular ROS levels was observed by compound G37. These compounds bind at the active pocket of the alpha/beta-tubulin with higher number of stable hydrogen bonds, hydrophobic and arene-cation interactions confirmed by molecular modeling studies.

  DOI：

  10.1016/j.bioorg.2019.103188

文献信息

• Quinazoline thiazolinones
  申请人：Chen Li

  公开号：US20060084804A1

  公开（公告）日：2006-04-20

  Quinazoline thiazolinone derivatives which demonstrate CDK1 antiproliferative activity and are useful as anti-cancer agents.

  喹唑啉噻唑酮衍生物具有CDK1抗增殖活性，并可用作抗癌剂。
• Thiazolinone 4-monosubstituted quinolines
  申请人：Chen Li

  公开号：US20060063805A1

  公开（公告）日：2006-03-23

  Thiazolinone monosubstituted quinoline derivatives where the quinoline ring is mono-substituted at the 4 positions which derivatives demonstrates CDK1 antiproliferative activity and are useful as anti-cancer agents.

  噻唑啉单取代喹啉衍生物，在其中喹啉环在4个位置单取代，这些衍生物表现出CDK1抗增殖活性，并可用作抗癌剂。
• 1,5-naphthyridine azolinone
  申请人：Liu Jin-Jun

  公开号：US20060084673A1

  公开（公告）日：2006-04-20

  1,5-Naphthyridine azolinone derivatives are disclosed. These compounds are inhibitors of CDK1 and are useful as antiproliferative agents, such as anti-cancer agents.

  揭示了1,5-萘啶唑啉衍生物。这些化合物是CDK1的抑制剂，可用作抗增殖剂，如抗癌剂。
• Azaindole thiazolinones
  申请人：Chen Shaoqing

  公开号：US20060084674A1

  公开（公告）日：2006-04-20

  Azaindole thiazolinone derivatives which demonstrate CDK1 and CDK2 antiproliferative activities and are useful as anti-cancer agents.

  Azaindole thiazolinone衍生物表现出CDK1和CDK2的抗增殖活性，并可用作抗癌剂。
• Substituted 1,5-naphthyridine azolinones
  申请人：Liu Jin-Jun

  公开号：US20060223843A1

  公开（公告）日：2006-10-05

  Substituted 1,5-naphthyridine azolinones inhibit Cdk1 and are selective against Cdk2 and Cdk4. These compounds and their pharmaceutically acceptable salts have antiproliferative activity and are useful as anti-cancer agents.

  1,5-萘啶咪唑酮替代物抑制Cdk1，对Cdk2和Cdk4具有选择性。这些化合物及其药学上可接受的盐具有抗增殖活性，并可用作抗癌剂。